Login

Insights from Aptos Biosciences CEO on Drug Development and Healthcare Systems at Blum Burton Conference | William Rice, CEO, Aptose Biosciences Inc . 00:10:00

Share On Facebook Share On Twitter

The CEO of a biotech company discusses the progress and potential of their drug development programs for treating acute myeloid leukemia and b-cell malignancies, along with insights on healthcare systems, during an interview at the Blum Burton health care investment conference in Toronto.

Recent Videos

00:10:00
Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Pablo Pereiro Discusses Squirrel Media’s 63% Profit Growth and 14.7% Stock Surge | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Steve Oliver of musicMagpie Discusses Circular Economy and Company's Growth Strategy | Steve Oliver , CEO , musicMagpie PLC.
00:10:00
Revolutionizing Healing with Naturally Derived Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.
00:10:00
Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Leading the Charge in the Psychedelic Movement with Filament Health | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Pini Mandel on the Power of Dynamic Pricing to Boost Retail KPIs and Customer Satisfaction | Pini Mandel , CEO , Quicklizard Ltd.
00:10:00
Jean Michel Ng Tseung, New CEO of MCB Group, Shares Vision for a Sustainable Future | Jean Michel Ng Tseung , CEO , MCB Group Ltd.
00:10:00
Viktor Garmiani Unveils Candles Scandinavia’s Q4 Report Highlights | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Squirrel Media's Record-Breaking Year: CEO Pablo Pereiro Discusses Key Strategies and Global Expansion | Pablo Pereiro , CEO , Squirrel Media SA.

Suggestions

00:10:00
Andrew Harding of Aurizon: Insights on 1H22 Performance and Company Update | Andrew Harding - CEO of Aurizon
00:10:00
Bill Keffer Discusses Financial Planning with Marie Swift at NAPFA Midwest Symposium, July 2012
00:00:00
Oncimmune's strategic pivot aims for robust growth in 2024 - Martin Gouldstone Chief Executive Officer, Oncimmune Holdings
00:10:00
Mountain Province Diamonds: Current Operations and Industry Outlook
00:10:00
Financial Performance Overview of UAP Holdings PLC: A Year of Contrasting Results | Arthur Oginga, CEO ,  UAP Old Mutual Holdings.
00:10:00
Key Wins and Future Outlook with Justin Hyland and Will Douglas | Justin Hyland, Managing Director, Hyland Financial Planning.
00:10:00
Global venture capital firm focused on multi stage, sector-focused investments|Jenny Lee,Managing Partner,GGV Capital
00:10:00
Investor in the trenches supporting you to close enterprise|Jessica Lin,Co-Founder and General Partner,Work-Bench
00:10:00
CJ Klaas on Navigating Current Markets and Investment Volatility | C.J. Klaas, President, Klaas Financial.
00:10:00
Carlos Lee EPIC Interview Aixtron at SSL 2012 in Guangzhou, China | Dr. Felix J. Grawert, CO-President, Aixtron SEAIXXF:PKC
00:10:00
Proactive their aim is to become a leading provider of digital services to their clients through two complimentary businesses|Alan Rommel, chief executive of Parity Group Plc
00:10:00
Improving sight in patients with severe vision loss|Brian M Strem,CEO,EyeGate Pharmaceuticals Inc

© 2017 - Townhall + Tv